Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Net Cash Flow: 2022-2025

Historic Net Cash Flow for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to -$7.9 million.

  • Praxis Precision Medicines' Net Cash Flow fell 133.56% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.1 million, marking a year-over-year decrease of 128.30%. This contributed to the annual value of $134.1 million for FY2024, which is 581.09% up from last year.
  • Praxis Precision Medicines' Net Cash Flow amounted to -$7.9 million in Q3 2025, which was up 3.24% from -$8.2 million recorded in Q2 2025.
  • Praxis Precision Medicines' Net Cash Flow's 5-year high stood at $70.7 million during Q1 2024, with a 5-year trough of -$61.5 million in Q1 2022.
  • Moreover, its 3-year median value for Net Cash Flow was -$6.8 million (2024), whereas its average is $8.0 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 2,298.18% in 2023, then surged by 336.17% in 2024.
  • Praxis Precision Medicines' Net Cash Flow (Quarterly) stood at -$825,000 in 2022, then crashed by 2,298.18% to -$19.8 million in 2023, then spiked by 336.17% to $46.7 million in 2024, then plummeted by 133.56% to -$7.9 million in 2025.
  • Its Net Cash Flow was -$7.9 million in Q3 2025, compared to -$8.2 million in Q2 2025 and -$49.8 million in Q1 2025.